Epicardial adipose tissue predicts mortality in incident hemodialysis patients: A substudy of the Renagel in New Dialysis trial

Nephrology Dialysis Transplantation

Volumn 28, Issue 10, 2013, Pages 2586-2595

  D'Marco, Luis G ^a   Bellasi, Antonio ^b,c   Kim, Sunjin ^d   Chen, Zhengjia ^d   Block, Geoffrey A ^e   Raggi, Paolo ^f,g  

^a Universidad de Oriente Nucleo Bolivar   (Venezuela)

^b SANT ANNA HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d EMORY UNIVERSITY   (United States)

^e Denver Nephrology   (United States)

^f UNIVERSITY OF ALBERTA   (Canada)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; epicardial adipose tissue; hemodialysis; mortality

Indexed keywords

CALCIUM; CALCIUM DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATE; PHOSPHATE BINDING AGENT; SEVELAMER; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGE; AORTA; ARTICLE; BODY MASS; CARDIAC IMAGING; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; DIASTOLIC BLOOD PRESSURE; EPICARDIAL ADIPOSE TISSUE; EPICARDIUM; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHOSPHATE BLOOD LEVEL; POST HOC ANALYSIS; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ATHEROSCLEROSIS; EPICARDIAL ADIPOSE TISSUE; HEMODIALYSIS; MORTALITY;

ADIPOSE TISSUE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCIUM; CHELATING AGENTS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; POLYAMINES; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES;

EID: 84884961458     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft264     Document Type: Article

References (32)

1. Ho E, Shimada Y. Formation of the epicardium studied with the scanning electron microscope. Dev Biol 1978; 66: 579-585 (Pubitemid 9043828)
2. Baker AR, Silva NF, Quinn DW et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5: 1
3. Mazurek T, Zhang L, Zalewski A et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-2466 (Pubitemid 37444406)
4. Subbotin VM. Neovascularization of coronary tunica intima (DIT) is the cause of coronary atherosclerosis. Lipoproteins invade coronary intima via neovascularization from adventitial vasa vasorum, but not from the arterial lumen: a hypothesis. Theor Biol Med Model 2012; 9: 11
5. Alexopoulos N, McLean DS, Janik M et al. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010; 210: 150-154
6. Tavora F, Kutys R, Li L et al. Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis. Cardiovasc Pathol 2010; 19: e61-e68
7. Ding J, Hsu FC, Harris TB et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009; 90: 499-504
8. Mahabadi AA, Berg MH, Lehmann N et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. J Am Coll Cardiol 2013; 61: 1388-1395
9. Turkmen K, Kayikcioglu H, Ozbek O et al. The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/ calcification syndrome in ESRD patients. Clin J Am Soc Nephrol 2011; 6: 1920-1925
10. Turan MN, Gungor O, Asci G et al. Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 2013; 226: 129-133
11. Block GA, Spiegel DM, Ehrlich J et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824 (Pubitemid 43169927)
12. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832 (Pubitemid 20101575)
13. Gorter PM, van Lindert AS, de Vos AM et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008; 197: 896-903 (Pubitemid 351417890)
14. Kalbfleisch JD, Prentice RL. The Statsitical Analysis of Failure Time Data. Hoboken, NJ : JWiley and Sons, 1980
15. Cox D. Regression models and life tables. J Royal Stat Society 1972; B34: 187-220
16. Uno H, Cai T, Pencina MJ et al. On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 2011; 30: 1105-1117
17. Gronnesby JK, Borgan ∅. A method for checking regression models in survival analysis based on the risk score. Lifetime Data Analysis 1996; 2: 315-328 (Pubitemid 126415889)
18. Pencina MJ, D'Agostino RB, Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30: 11-21
19. Tripepi G, Jager KJ, Dekker FW et al. Statistical methods for the assessment of prognostic biomarkers( part II): calibration and reclassification. Nephrol Dial Transplant 2010; 25: 1402-1405
20. Tripepi G, Jager KJ, Dekker FW et al. Statistical methods for the assessment of prognostic biomarkers ( part I): discrimination. Nephrol Dial Transplant 2010; 25: 1399-1401
21. Xu Y, Cheng X, Hong K et al. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron Artery Dis 2012; 23: 227-233
22. Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441
23. Cheng KH, Chu CS, Lee KT et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes 2008; 32: 268-274
24. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 2007; 153: 907-917 (Pubitemid 46809849)
25. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911 (Pubitemid 29197978)
26. Dey D, Nakazato R, Li D et al. Epicardial and thoracic fat-noninvasive measurement and clinical implications. Cardiovas Diagn Ther 2012; 2: 85-93
27. Nakazato R, Rajani R, Cheng VY et al. Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis 2012; 220: 139-144
28. Alexopoulos N, Melek BH, Arepalli CD et al. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic postmenopausal women: a substudy of the BELLES (Beyond Endorsed Lipid Lowering with EBT Scanning) trial. J Am Coll Cardiol 2013; 61: 1956-1961
29. Wu YW, Kao HL, Huang CL et al. The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. Eur J Nucl Med Mol Imaging 2012; 39: 399-407
30. Abe M, Matsuda M, Kobayashi H et al. Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88- independent IRF3/IFN-beta pathway in macrophages. Arterioscler Thromb Vasc Biol 2008; 28: 871-877 (Pubitemid 351544101)
31. Dong L, Kerwin WS, Chen H et al. Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum-evaluation by using dynamic contrast-enhanced MR imaging. Radiology 2011; 260: 224-231
32. Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192